info@flamel.com
 
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
Archives


Latest News
Medusa®

A Versatile Nano Carrier for the Delivery of Native Proteins

Medusa®, a self-assembled poly-aminoacid nanogel system, is a versatile protein carrier for the development of novel and second-generation long-acting native protein drugs. more info

Micropump® Technologies
From Pediatric to Geriatric Uses

Controlled-release systems permitting either extended (Micropump® I) or both delayed and extended (Micropump® II) delivery of small molecule drugs.

more info

December 22, 2008
Flamel Technologies Announces New Micropump and Medusa Contracts, and a Research Collaboration with Pfizer

November 03, 2008
Flamel Technologies Announces Third Quarter Results and New Medusa Agreement

October 28, 2008
Flamel Technologies Announces Projected Release Date of Third Quarter Results,
Conference Call

September 18, 2008
Flamel Technologies Announces Announces Payment from Wyeth Pharmaceuticals

August 6, 2008
Flamel Technologies Announces Second Quarter Results and New Medusa Contracts

June 03, 2008
Flamel Technologies Announces Results of Annual Meeting

May 13, 2008
Flamel Technologies Announces First Quarter Results, Milestone Payment, and Trigger Lock Feasibility Agreement

April 25, 2008
Flamel Technologies Presents Results of Two Week Study of Interferon Alpha XL at the European Association for the Study of the Liver

March 3, 2008
Flamel Technologies Announces Fourth Quarter and Year-End Results; Fourth quarter includes strong clinical results; new agreements; and cash maintained at $41 million

March 3, 2008
Flamel Technologies Announces Nomination of Dr. Frank Fildes to Board of Directors; Flamel Technologies also announces departure of Michel Finance and appointment of Sian Crouzet

February 25, 2008
Flamel Technologies Announces Projected Release Date of Fourth Quarter and Annual Results, Conference Call